109 related articles for article (PubMed ID: 16763314)
1. A novel potent non-nucleoside reverse transcriptase inhibitor acylthiocarbamate derivative with extensive intramolecular pi-pi interactions.
Mugnoli A; Borassi A; Spallarossa A; Cesarini S
Acta Crystallogr C; 2006 Jun; 62(Pt 6):o315-7. PubMed ID: 16763314
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.
Spallarossa A; Cesarini S; Ranise A; Ponassi M; Unge T; Bolognesi M
Biochem Biophys Res Commun; 2008 Jan; 365(4):764-70. PubMed ID: 18035053
[TBL] [Abstract][Full Text] [Related]
3. Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Parallel synthesis, molecular modelling and structure-activity relationship studies on O-[2-(hetero)arylethyl]-N-phenylthiocarbamates.
Cesarini S; Spallarossa A; Ranise A; Fossa P; La Colla P; Sanna G; Collu G; Loddo R
Bioorg Med Chem; 2008 Apr; 16(7):4160-72. PubMed ID: 18226532
[TBL] [Abstract][Full Text] [Related]
4. Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate.
Cesarini S; Spallarossa A; Ranise A; Bruno O; La Colla P; Secci B; Collu G; Loddo R
Bioorg Med Chem; 2008 Apr; 16(7):4173-85. PubMed ID: 18226533
[TBL] [Abstract][Full Text] [Related]
5. Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Spallarossa A; Cesarini S; Ranise A; Bruno O; Schenone S; La Colla P; Collu G; Sanna G; Secci B; Loddo R
Eur J Med Chem; 2009 Apr; 44(4):1650-63. PubMed ID: 18954921
[TBL] [Abstract][Full Text] [Related]
6. Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.
Su DS; Lim JJ; Tinney E; Wan BL; Young MB; Anderson KD; Rudd D; Munshi V; Bahnck C; Felock PJ; Lu M; Lai MT; Touch S; Moyer G; Distefano DJ; Flynn JA; Liang Y; Sanchez R; Prasad S; Yan Y; Perlow-Poehnelt R; Torrent M; Miller M; Vacca JP; Williams TM; Anthony NJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):5119-23. PubMed ID: 19631528
[TBL] [Abstract][Full Text] [Related]
7. Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.
Cichero E; Cesarini S; Fossa P; Spallarossa A; Mosti L
Eur J Med Chem; 2009 May; 44(5):2059-70. PubMed ID: 19046616
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
Tucker TJ; Sisko JT; Tynebor RM; Williams TM; Felock PJ; Flynn JA; Lai MT; Liang Y; McGaughey G; Liu M; Miller M; Moyer G; Munshi V; Perlow-Poehnelt R; Prasad S; Reid JC; Sanchez R; Torrent M; Vacca JP; Wan BL; Yan Y
J Med Chem; 2008 Oct; 51(20):6503-11. PubMed ID: 18826204
[TBL] [Abstract][Full Text] [Related]
9. Water-nucleobase "stacking": H-pi and lone pair-pi interactions in the atomic resolution crystal structure of an RNA pseudoknot.
Sarkhel S; Rich A; Egli M
J Am Chem Soc; 2003 Jul; 125(30):8998-9. PubMed ID: 15369340
[TBL] [Abstract][Full Text] [Related]
10. Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Cesarini S; Spallarossa A; Ranise A; Schenone S; Bruno O; La Colla P; Casula L; Collu G; Sanna G; Loddo R
Bioorg Med Chem; 2008 Jun; 16(12):6353-63. PubMed ID: 18502646
[TBL] [Abstract][Full Text] [Related]
11. Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
O'Meara JA; Jakalian A; LaPlante S; Bonneau PR; Coulombe R; Faucher AM; Guse I; Landry S; Racine J; Simoneau B; Thavonekham B; Yoakim C
Bioorg Med Chem Lett; 2007 Jun; 17(12):3362-6. PubMed ID: 17451954
[TBL] [Abstract][Full Text] [Related]
12. Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Spallarossa A; Cesarini S; Ranise A; Schenone S; Bruno O; Borassi A; La Colla P; Pezzullo M; Sanna G; Collu G; Secci B; Loddo R
Eur J Med Chem; 2009 May; 44(5):2190-201. PubMed ID: 19058881
[TBL] [Abstract][Full Text] [Related]
13. Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors.
Barreca ML; De Luca L; Iraci N; Rao A; Ferro S; Maga G; Chimirri A
J Chem Inf Model; 2007; 47(2):557-62. PubMed ID: 17274611
[TBL] [Abstract][Full Text] [Related]
14. Synthetic chemistry-led creation of a difluorinated biaryl ether non-nucleoside reverse transcriptase inhibitor.
Jones LH; Randall A; Barba O; Selby MD
Org Biomol Chem; 2007 Nov; 5(21):3431-3. PubMed ID: 17943200
[TBL] [Abstract][Full Text] [Related]
15. Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors.
Monforte AM; Rao A; Logoteta P; Ferro S; De Luca L; Barreca ML; Iraci N; Maga G; De Clercq E; Pannecouque C; Chimirri A
Bioorg Med Chem; 2008 Aug; 16(15):7429-35. PubMed ID: 18585918
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase.
Ren J; Stammers DK
Virus Res; 2008 Jun; 134(1-2):157-70. PubMed ID: 18313784
[TBL] [Abstract][Full Text] [Related]
17. A locked derivative of 8-aza-7-deazaadenosine.
Pasternak A; Kierzek R; Gdaniec Z; Gdaniec M
Acta Crystallogr C; 2008 Aug; 64(Pt 8):o467-70. PubMed ID: 18682661
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
Boojamra CG; Parrish JP; Sperandio D; Gao Y; Petrakovsky OV; Lee SK; Markevitch DY; Vela JE; Laflamme G; Chen JM; Ray AS; Barron AC; Sparacino ML; Desai MC; Kim CU; Cihlar T; Mackman RL
Bioorg Med Chem; 2009 Feb; 17(4):1739-46. PubMed ID: 19179082
[TBL] [Abstract][Full Text] [Related]
19. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
20. Intramolecular cation-pi interactions as the driving force to restrict the conformation of certain nucleosides.
Casanova E; Priego EM; Jimeno ML; Aguado L; Negri A; Gago F; Camarasa MJ; Pérez-Pérez MJ
J Org Chem; 2010 Mar; 75(6):1974-81. PubMed ID: 20192191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
